homehealthcare NewsIpca Labs Q3 net profit rises 35% to Rs 267.56 cr

Ipca Labs Q3 net profit rises 35% to Rs 267.56 cr

Indian formulations income was up 8 percent at Rs 523.16 crore for the quarter ended December this fiscal, and export income rose 21 percent to Rs 709.25 crore, the company said.

By PTI Feb 4, 2021 4:10:54 PM IST (Published)


Drug firm Ipca Laboratories on Thursday reported a 35.44 percent rise in consolidated net profit to Rs 267.56 crore for the third quarter ended December 2020, on the back of robust sales in domestic and international markets. The company had posted a net profit of Rs197.54 crore for the same period of the previous fiscal, Ipca Labs said in a BSE filing.